Nextgen Healthcare Inc (NASDAQ:NXGN) has been given a consensus broker rating score of 3.00 (Hold) from the fourteen analysts that provide coverage for the stock, Zacks Investment Research reports. Three analysts have rated the stock with a strong sell recommendation, eight have given a hold recommendation and three have given a strong buy recommendation to the company. Nextgen Healthcare’s rating score has improved by 6.8% from three months ago as a result of various analysts’ ratings changes.
Brokers have set a 12 month consensus price objective of $18.32 for the company and are predicting that the company will post $0.15 EPS for the current quarter, according to Zacks. Zacks has also given Nextgen Healthcare an industry rank of 90 out of 257 based on the ratings given to related companies.
Get Nextgen Healthcare alerts: A number of research firms recently commented on NXGN. Morgan Stanley raised shares of Nextgen Healthcare from an “underweight” rating to an “equal weight” rating and increased their target price for the company from $12.00 to $16.00 in a research report on Thursday, November 1st. Zacks Investment Research downgraded shares of Nextgen Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, November 26th. TheStreet downgraded shares of Nextgen Healthcare from a “b-” rating to a “c+” rating in a research report on Wednesday, November 21st. KeyCorp dropped their target price on shares of Nextgen Healthcare from $17.00 to $16.00 and set an “underweight” rating on the stock in a research report on Wednesday, October 31st. Finally, Cantor Fitzgerald dropped their target price on shares of Nextgen Healthcare from $26.00 to $23.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 31st.
Several hedge funds and other institutional investors have recently bought and sold shares of NXGN. BlackRock Inc. purchased a new position in shares of Nextgen Healthcare in the 3rd quarter valued at $148,229,000. Vanguard Group Inc. purchased a new position in shares of Nextgen Healthcare in the 3rd quarter valued at $106,770,000. Dimensional Fund Advisors LP purchased a new position in shares of Nextgen Healthcare in the 3rd quarter valued at $47,298,000. Investment Counselors of Maryland LLC purchased a new position in Nextgen Healthcare during the 3rd quarter worth $24,953,000. Finally, Elk Creek Partners LLC purchased a new position in Nextgen Healthcare during the 3rd quarter worth $14,990,000. 68.16% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ:NXGN traded up $0.39 during trading hours on Tuesday, reaching $17.55. The stock had a trading volume of 626,705 shares, compared to its average volume of 185,935. Nextgen Healthcare has a 1 year low of $12.24 and a 1 year high of $23.73. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.12. The company has a market cap of $1.13 billion, a PE ratio of 30.79, a P/E/G ratio of 3.45 and a beta of 0.93.
Nextgen Healthcare (NASDAQ:NXGN) last posted its earnings results on Tuesday, October 30th. The company reported $0.24 EPS for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.05. The firm had revenue of $130.30 million for the quarter, compared to the consensus estimate of $134.55 million. Nextgen Healthcare had a net margin of 1.17% and a return on equity of 10.23%. The company’s revenue was down 1.7% on a year-over-year basis. During the same period last year, the firm posted $0.22 EPS. As a group, equities research analysts expect that Nextgen Healthcare will post 0.57 EPS for the current year.
Nextgen Healthcare Company Profile
NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.
Read More: Swap
Get a free copy of the Zacks research report on Nextgen Healthcare (NXGN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Nextgen Healthcare Nextgen Healthcare
